_________ false
אורמד פארמסוטיקלס אינק 2 381
ORAMED PHARMACEUTICALS INC
Corporation no: 980376008 14166

Israel Securities Authority   Tel Aviv Stock Exchange   C003 ( Public )   Reported via MAGNA: 01/06/2023
  www.isa.gov.il     www.tase.co.il       Reference: 2023-02-051175 Time of broadcast: 00:46 00:46

Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on
Form_4_-_Nadav_Kidron_-_May_31_2023_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
       

Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 02/05/2023
Address: Avenue of the Americas 01185 , New York 10036   New York , USA Tel: 844-9672633 , 02-5660001 Fax: 02-5660004
E-mail address: office@oramed.com   Company site: www.oramed.com

Previous names of reporting entity:

Name of the Signatory: DEROVAN NETANEL MOSHE Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary Name of Employer Company:
Address: Mamila 20 , Jerusalem 9414904 Telephone: 02-5660001 Facsimile: E-mail: netanel@oramed.com 1
USA